Elize Sturkenboom – van de Wetering, Venture Leader of Lung Oncology at Phillips Healthcare, discusses the diagnosis and treatment of lung cancer through new minimally invasive therapy.
Optimising a drug’s ability to reach diseased body parts in adequate levels while avoiding healthy body parts – its tissue exposure and selectivity – is critical to therapeutic optimisation.
Tara M. DeSilva from the Department of Neurosciences, Cleveland Clinic, walks us through regenerative therapies for multiple sclerosis, including comment on clues from studying normal brain development.
Rob Irons, Senior Manager at Hinduja Global Solutions, discusses whether public sector customer service has improved with the adoption of cloud technology.
Eugene M. Terentjev, a professor of Polymer Physics at the University of Cambridge looks at smart, reusable adhesion through liquid crystalline elastomers.
One of JPND’s key objectives is to fortify its work in brain health partnerships in Europe to better combat the challenges of neurodegenerative disease (ND).
Productivity is vital for all organisations to thrive, and in today’s always-on society, many employees are feeling the pressure to get more work done than ever before.
The majority of businesses supplying products and services into the NHS through surgical pathways cannot have failed to be aware of the declared intent by the NHS to decarbonise the health system.
The UK economy is in recovery: can we be confident that the government is being prudent with the finances at their disposal? What about the physical destruction of SSDs?
Updates to the Castle Hill Hospital in Hull show that solar powered hospitals may be the next step towards net zero health in the NHS decarbonisation strategy.
Spiralling inflation, rising energy bills and an escalating cost of living crisis have left millions of people struggling to afford basic necessities; could future predictive modelling stop this from happening again.
